Testing Novel Drug Design Engines for Cancer for Improved Efficacy and Toxicity Mitigation

  • Exploring the challenges of delivering RNAi to cancer
  • Evaluating potential strategies to enable the development of RNAi-based drugs
  • Presenting examples of emerging RNAi-based therapeutics for cancer